Body composition and adipokines changes after initial treatment with darunavir-ritonavir plus either raltegravir or tenofovir disoproxil fumarate-emtricitabine: A substudy of the NEAT001/ANRS143 randomised trial.
Jose Ignacio BernardinoAmanda MocroftCedrick WalletStéphane de WitChristine KatlamaPeter ReissPatrick W MallonLaura RichertJean-Michel MolinaHernando KnobelPhilippe MorlatAbdel BabikerAnton PozniacFrancois RaffiJose R Arribasnull nullPublished in: PloS one (2019)
After week 96 a N(t)RTI sparing regimen of DRV/r + RAL produced a numerically greater percentage increase in body composition variables with only change in trunk fat mass and BMI being significant.